se ha leído el artículo
array:23 [ "pii" => "S1578219019300460" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.10.023" "estado" => "S300" "fechaPublicacion" => "2019-04-01" "aid" => "2104" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2018" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2019;110:181" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 7 "formatos" => array:3 [ "EPUB" => 1 "HTML" => 5 "PDF" => 1 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731018305015" "issn" => "00017310" "doi" => "10.1016/j.ad.2018.10.009" "estado" => "S300" "fechaPublicacion" => "2019-04-01" "aid" => "2104" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2019;110:181" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 246 "formatos" => array:2 [ "HTML" => 174 "PDF" => 72 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>" "titulo" => "Azatioprina en el tratamiento de la dermatitis atópica grave en pediatría. Experiencia en un hospital de referencia en España" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "181" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Azathioprine in the Treatment of Severe Pediatric Atopic Dermatitis: Experience in a Referral Hospital in Spain" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Vicente Villa" "autores" => array:1 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Vicente Villa" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219019300460" "doi" => "10.1016/j.adengl.2018.10.023" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019300460?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018305015?idApp=UINPBA000044" "url" => "/00017310/0000011000000003/v1_201904030618/S0001731018305015/v1_201904030618/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219019300563" "issn" => "15782190" "doi" => "10.1016/j.adengl.2019.02.017" "estado" => "S300" "fechaPublicacion" => "2019-04-01" "aid" => "2131" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Actas Dermosifiliogr. 2019;110:182-92" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 24 "formatos" => array:3 [ "EPUB" => 2 "HTML" => 21 "PDF" => 1 ] ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Adverse Hair Reactions to New Targeted Therapies for Cancer" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:3 [ 0 => "en" 1 => "en" 2 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "182" "paginaFinal" => "192" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Reacciones capilares de las nuevas terapias diana dirigidas contra el cáncer" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 1 "multimedia" => array:5 [ "identificador" => "fig0030" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 1085 "Ancho" => 1285 "Tamanyo" => 120868 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.F. Mir-Bonafé, D. Saceda-Corralo, S. Vañó-Galván" "autores" => array:3 [ 0 => array:2 [ "nombre" => "J.F." "apellidos" => "Mir-Bonafé" ] 1 => array:2 [ "nombre" => "D." "apellidos" => "Saceda-Corralo" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "Vañó-Galván" ] ] ] ] "resumen" => array:1 [ 0 => array:3 [ "titulo" => "Graphical abstract" "clase" => "graphical" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0030"></elsevierMultimedia></p></span>" ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731018305763" "doi" => "10.1016/j.ad.2018.10.019" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018305763?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019300563?idApp=UINPBA000044" "url" => "/15782190/0000011000000003/v1_201904030645/S1578219019300563/v1_201904030645/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "Azathioprine in the Treatment of Severe Pediatric Atopic Dermatitis: Experience in a Referral Hospital in Spain" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "181" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "A. Vicente Villa" "autores" => array:1 [ 0 => array:3 [ "nombre" => "A." "apellidos" => "Vicente Villa" "email" => array:1 [ 0 => "Avicente@sjdhospitalbarcelona.org" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, España" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Azatioprina en el tratamiento de la dermatitis atópica grave en pediatría. Experiencia en un hospital de referencia en España" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Atopic dermatitis is the most frequent inflammatory skin disease in children and one for which we do not yet have standardized treatment guidelines. Most children and adolescents have mild forms that are controlled with topical treatments. However, in moderate to severe cases that cannot be appropriately managed with topical treatments, other options such as phototherapy or systemic treatment must be considered. None of the classic systemic treatments (ciclosporin, azathioprine, methotrexate, mycophenolate mofetil) include the indication for treatment of atopic dermatitis in children and adolescents in their summary of product characteristics. In addition, there are very few publications on pediatric patients to help us in clinical practice.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">1,2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">In the present issue, Noguera-Morel et al.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">3</span></a> provide a retrospective review of children with severe atopic dermatitis treated with azathioprine over a 10-year period (2007-2017) at Hospital Infantil Universitario Niño Jesús, Madrid, Spain. The retrospective review includes 11 patients with a mean age of 13 years (range, 8-18 years). The authors highlight the effectiveness of the drug with complete or near-complete clearance in 7 of 9 patients at 12-16 weeks of treatment. These findings are somewhat superior to those published elsewhere and similar to those reported for other immunosuppressants. As for safety, only 2 patients had to suspend treatment because of gastrointestinal adverse events.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The authors agree with other specialists that the main drawbacks are the time to response (approximately 3 months) and the need for close monitoring. This publication advocates the use of azathioprine as a systemic treatment option in pediatric patients, albeit not as a first-choice drug.</p><p id="par0020" class="elsevierStylePara elsevierViewall">In the coming years, the advent of new biologics for the treatment of atopic dermatitis in children will show us where classic immunosuppressants stand.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Vicente Villa A. Azatioprina en el tratamiento de la dermatitis atópica grave en pediatría. Experiencia en un hospital de referencia en España. Actas Dermosifiliogr. 2019;110:181.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib0020" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral azathioprine for recalcitrant pediatric atopic dermatitis: Clinical response and thiopurine monitoring" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Caufield" 1 => "W.L. Tom" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2012.07.001" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2013" "volumen" => "68" "paginaInicial" => "29" "paginaFinal" => "35" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22892285" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0025" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "N.R. Fuggle" 1 => "W. Bragoli" 2 => "A. Mahto" 3 => "M. Glover" 4 => "A.E. Martinez" 5 => "V.A. Kinsler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2014.08.048" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2015" "volumen" => "72" "paginaInicial" => "108" "paginaFinal" => "114" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25440430" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0030" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estudio retrospectivo del tratamiento sistémico de la dermatitis atópica grave con azatioprina. Eficacia y tolerancia en 11 pacientes pediátricos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "L. Noguera-Morel" 1 => "N. Knöpfel" 2 => "A. Torrelo" 3 => "A. Hernández-Martín" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2018" "volumen" => "110" "paginaInicial" => "227" "paginaFinal" => "231" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000011000000003/v1_201904030645/S1578219019300460/v1_201904030645/en/main.assets" "Apartado" => array:4 [ "identificador" => "66476" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Commentaries" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011000000003/v1_201904030645/S1578219019300460/v1_201904030645/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019300460?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 6 | 7 | 13 |
2024 Octubre | 69 | 41 | 110 |
2024 Septiembre | 73 | 16 | 89 |
2024 Agosto | 87 | 44 | 131 |
2024 Julio | 72 | 43 | 115 |
2024 Junio | 75 | 40 | 115 |
2024 Mayo | 69 | 25 | 94 |
2024 Abril | 67 | 27 | 94 |
2024 Marzo | 64 | 28 | 92 |
2024 Febrero | 64 | 28 | 92 |
2024 Enero | 55 | 31 | 86 |
2023 Diciembre | 60 | 15 | 75 |
2023 Noviembre | 72 | 22 | 94 |
2023 Octubre | 60 | 20 | 80 |
2023 Septiembre | 49 | 27 | 76 |
2023 Agosto | 27 | 11 | 38 |
2023 Julio | 32 | 36 | 68 |
2023 Junio | 43 | 23 | 66 |
2023 Mayo | 38 | 23 | 61 |
2023 Abril | 20 | 18 | 38 |
2023 Marzo | 33 | 21 | 54 |
2023 Febrero | 23 | 16 | 39 |
2023 Enero | 28 | 12 | 40 |
2022 Diciembre | 57 | 33 | 90 |
2022 Noviembre | 21 | 30 | 51 |
2022 Octubre | 28 | 12 | 40 |
2022 Septiembre | 28 | 36 | 64 |
2022 Agosto | 25 | 26 | 51 |
2022 Julio | 22 | 33 | 55 |
2022 Junio | 21 | 29 | 50 |
2022 Mayo | 30 | 31 | 61 |
2022 Abril | 30 | 34 | 64 |
2022 Marzo | 36 | 56 | 92 |
2022 Febrero | 29 | 25 | 54 |
2022 Enero | 26 | 34 | 60 |
2021 Diciembre | 33 | 34 | 67 |
2021 Noviembre | 29 | 39 | 68 |
2021 Octubre | 38 | 43 | 81 |
2021 Septiembre | 39 | 39 | 78 |
2021 Agosto | 29 | 26 | 55 |
2021 Julio | 17 | 17 | 34 |
2021 Junio | 21 | 20 | 41 |
2021 Mayo | 32 | 33 | 65 |
2021 Abril | 40 | 45 | 85 |
2021 Marzo | 49 | 24 | 73 |
2021 Febrero | 58 | 13 | 71 |
2021 Enero | 43 | 12 | 55 |
2020 Diciembre | 27 | 10 | 37 |
2020 Noviembre | 17 | 19 | 36 |
2020 Octubre | 14 | 7 | 21 |
2020 Septiembre | 27 | 7 | 34 |
2020 Agosto | 19 | 22 | 41 |
2020 Julio | 22 | 16 | 38 |
2020 Junio | 22 | 22 | 44 |
2020 Mayo | 21 | 8 | 29 |
2020 Abril | 17 | 7 | 24 |
2020 Marzo | 13 | 7 | 20 |
2020 Febrero | 3 | 0 | 3 |
2019 Junio | 2 | 0 | 2 |
2019 Mayo | 2 | 0 | 2 |
2019 Abril | 1 | 1 | 2 |